Regal Investment Advisors LLC Intercept Pharmaceuticals, Inc. Transaction History

Regal Investment Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 04, 2019	SELL	$85.79 - $126.46 $2.29 Million - $3.37 Million	-26,688 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$88.49 - $127.55 $222,463 - $320,660	2,514 Added 10.4%	26,688 $3.37 Million
Q2 2018 Aug 10, 2018	SELL	$60.0 - $85.67 $320,220 - $457,220	-5,337 Reduced 18.08%	24,174 $2.03 Million
Q1 2018 Apr 25, 2018	SELL	$52.72 - $67.25 $33,529 - $42,771	-636 Reduced 2.11%	29,511 $1.82 Million
Q4 2017 Feb 06, 2018	BUY	$58.2 - $72.76 $1.75 Million - $2.19 Million	30,147	30,147 $1.76 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Regal Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Regal Investment Advisors LLC with notifications on news.